Historical record - last NADAC effective date: 6/21/2023
Product Information
QC IBUPROFEN 200 MG MINI SFGL is a generic product labeled by Chain Drug Marketing Association, priced at $0.0882 per EA under NDC 63868042720. Its NADAC has been published 24 times since Jan 18, 2023.
FDA first approved this application on Mar 24, 2009.
Strength
200 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868042720
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
6/21/2023
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA078682FDA Approved
3/24/2009
On Market Since
7/16/2020
Pharmacological Classes
Price Statistics
The NADAC for QC IBUPROFEN 200 MG MINI SFGL has been published 24 times since Jan 18, 2023, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0882 per EA |
|---|---|
| All-time high | $0.0979 (Feb 15, 2023) |
| All-time low | $0.0814 (May 17, 2023) |
| Median price | $0.0848 |
| Average price | $0.0879 |
| Largest weekly change | -13.4% (Feb 22, 2023) |
| Weeks tracked | 24 |
| Tracking since | Jan 18, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.9%
Last surveyed Jun 28, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QC IBUPROFEN 200 MG MINI SFGL?
The current National Average Drug Acquisition Cost (NADAC) for QC IBUPROFEN 200 MG MINI SFGL, manufactured by Chain Drug Marketing Association, is $0.0882 per EA (NDC 63868042720), effective Jun 28, 2023.
How has the price of QC IBUPROFEN 200 MG MINI SFGL changed over time?
Over the history we have for it, the NADAC for QC IBUPROFEN 200 MG MINI SFGL has declined 9.9%. It has been tracked across 24 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for QC IBUPROFEN 200 MG MINI SFGL?
Since Jan 18, 2023, the NADAC for QC IBUPROFEN 200 MG MINI SFGL has ranged from a low of $0.0814 (May 17, 2023) to a high of $0.0979 (Feb 15, 2023), with a median of $0.0848 per EA.
Are there cheaper alternatives to QC IBUPROFEN 200 MG MINI SFGL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG SOFTGEL, is $0.0780 per EA — about 12% below QC IBUPROFEN 200 MG MINI SFGL.
Who manufactures QC IBUPROFEN 200 MG MINI SFGL?
QC IBUPROFEN 200 MG MINI SFGL (NDC 63868042720) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.